Dolomite Appoints John Morris Scientific in Australia as Distributor for Microfluidic Services and Capabilities
News Oct 09, 2007
Dolomite has appointed John Morris Scientific Pty Ltd in Australia as a distributor for their microfluidic services and capabilities. John Morris Scientific will work with local clients helping secure new business opportunities and managing customer relations for Dolomite in Australia.
‘This is an exciting development for us,’ said Gillian Davis, Commercial Director of Dolomite. ‘This appointment reflects the increasing level of interest we are experiencing around the world from customers interested in working with us to bring their microfluidic concepts to market. Appointing a technical company as experienced and capable as John Morris Scientific will be instrumental in helping to secure business and manage customer relations in this territory.
Dolomite’s key strength lies in being able to offer a complete service to customers from problem conceptualization and feasibility testing through to full instrument design and development. This one-stop-shop model sets Dolomite apart from most other micro-fabrication firms and relies on them having employees with a broad technical knowledge, as well as expertise in microfabrication and microfluidics, together with instrument design and development capabilities.
‘At John Morris Scientific we recognize the growing level of demand from customers for a partner they can work with closely to help bring their concepts for microfluidic products to market,’ said Andre Wyzenbeek, Marketing and Sales Director at John Morris Scientific.
‘We have, therefore, teamed up with Dolomite to provide potential customers with effective local support, assisting Dolomite meet the ever increasing demand for their services in the field of application microfluidics.’
Instead of searching for a needle in a haystack, what if you were able to sweep the entire haystack to one side, leaving only the needle behind? That's the strategy researchers followed in developing a new microfluidic device that separates elusive circulating tumor cells (CTCs) from a sample of whole blood.READ MORE